MaaT Pharma SA (EPA: MAAT)

MaaT Pharma Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.15	24.28	35.25	43.31	19.91	5.41
Short-Term Investments	-	0.03	0.06	-	-	-
Cash & Short-Term Investments	31.15	24.31	35.31	43.31	19.91	5.41
Cash Growth	-11.32%	-31.14%	-18.46%	117.47%	268.01%	50.30%
Accounts Receivable	6.66	5.16	4.24	2.39	1.65	0.02
Other Receivables	0.64	1.04	0.78	0.98	0.59	1.43
Receivables	7.3	6.21	5.02	3.37	2.24	1.45
Inventory	0.18	0.19	0.05	0.03	-	0.03
Prepaid Expenses	1	1.13	1.58	0.43	0.04	0.04
Other Current Assets	1.02	0.15	0.16	0.13	0	0.05
Total Current Assets	40.65	31.99	42.12	47.27	22.19	6.97
Property, Plant & Equipment	8.52	9.17	0.97	1.11	1.1	0.43
Long-Term Investments	-	0.2	0.3	0.1	0.1	-
Other Intangible Assets	1.32	1.34	1.2	0.81	0.75	0.06
Long-Term Deferred Charges	-	-	-	-	-	0.05
Other Long-Term Assets	0.2	-	-	-	-0	0.06
Total Assets	50.92	42.93	44.73	49.42	24.28	7.57
Accounts Payable	5.7	6.35	4.51	2.47	1.4	1.68
Accrued Expenses	1.52	1.29	1.24	0.69	0.49	-
Short-Term Debt	-	-	-	-	-	7.05
Current Portion of Long-Term Debt	7.11	2.22	2.77	1.06	0.78	0.33
Current Portion of Leases	-	1.23	0.21	0.19	0.08	-
Current Income Taxes Payable	0.08	0.06	0.05	0.03	0.03	0.3
Other Current Liabilities	0.31	0.37	0.44	0.25	0.07	0.42
Total Current Liabilities	14.72	11.52	9.22	4.7	2.86	9.78
Long-Term Debt	4.41	5.75	7.94	3.98	4.72	0.8
Long-Term Leases	5.65	4.87	0.43	0.57	0.49	-
Other Long-Term Liabilities	0.36	0.15	0.23	0.19	0.19	1.48
Total Liabilities	25.31	22.47	17.92	9.56	8.34	12.06
Common Stock	1.39	1.16	0.99	0.99	0.66	0.29
Additional Paid-In Capital	35.43	37.38	38.32	46.46	19.91	0.34
Retained Earnings	-10.98	-17.86	-12.37	-7.6	-4.63	-5.13
Treasury Stock	-0.23	-0.22	-0.14	-	-	-
Comprehensive Income & Other	-0	-	-	-	-	0
Shareholders' Equity	25.61	20.47	26.81	39.86	15.94	-4.5
Total Liabilities & Equity	50.92	42.93	44.73	49.42	24.28	7.57
Total Debt	17.17	14.08	11.36	5.81	6.08	8.18
Net Cash (Debt)	13.98	10.24	23.95	37.5	13.84	-2.77
Net Cash Growth	-36.90%	-57.25%	-36.13%	171.01%	-	-
Net Cash Per Share	1.17	0.90	2.42	15.45	13.40	-2.68
Filing Date Shares Outstanding	13.92	11.6	11.54	9.89	1.03	1.03
Total Common Shares Outstanding	13.92	11.59	9.94	9.88	1.03	1.03
Working Capital	25.93	20.47	32.91	42.57	19.33	-2.82
Book Value Per Share	1.84	1.77	2.70	4.03	15.44	-4.36
Tangible Book Value	24.29	19.12	25.61	39.05	15.19	-4.56
Tangible Book Value Per Share	1.75	1.65	2.58	3.95	14.71	-4.41
Machinery	1.32	1.25	0.99	0.73	0.65	-
Construction In Progress	0.55	0.52	0.07	-	0.12	-

Source: S&P Capital IQ. Standard template. Financial Sources.